Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001437928 | SCV001640794 | likely benign | not provided | 2023-11-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501547 | SCV002804519 | likely benign | Diabetes mellitus, transient neonatal, 2; Hyperinsulinemic hypoglycemia, familial, 1; Leucine-induced hypoglycemia; Type 2 diabetes mellitus; Diabetes mellitus, permanent neonatal 3 | 2022-02-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004651655 | SCV005150339 | likely benign | Inborn genetic diseases | 2024-05-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |